Acasti Pharma Volatility
| ACSTDelisted Stock | USD 3.37 0.01 0.30% |
Acasti Pharma appears to be very risky, given 3 months investment horizon. Acasti Pharma secures Sharpe Ratio (or Efficiency) of 0.18, which signifies that the company had a 0.18% return per unit of standard deviation over the last 3 months. By analyzing Acasti Pharma's technical indicators, you can evaluate if the expected return of 0.9% is justified by implied risk. Please makes use of Acasti Pharma's risk adjusted performance of 0.0704, and Mean Deviation of 3.0 to double-check if our risk estimates are consistent with your expectations. Key indicators related to Acasti Pharma's volatility include:
30 Days Market Risk | Chance Of Distress | 30 Days Economic Sensitivity |
Acasti Pharma Stock volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of Acasti daily returns, and it is calculated using variance and standard deviation. We also use Acasti's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of Acasti Pharma volatility.
Acasti |
Since volatility provides investors with entry points to take advantage of stock prices, companies, such as Acasti Pharma can benefit from it. Downward market volatility can be a perfect environment for investors who play the long game. Here, they may decide to buy additional stocks of Acasti Pharma at lower prices. For example, an investor can purchase Acasti stock that has halved in price over a short period. This will lower your average cost per share, thereby improving your portfolio's performance when the markets normalize. Similarly, when the prices of Acasti Pharma's stock rises, investors can sell out and invest the proceeds in other equities with better opportunities. Investing when markets are volatile with better valuations will accord both investors and companies the opportunity to generate better long-term returns.
Moving against Acasti Stock
| 0.86 | HYMTF | Hyundai Motor | PairCorr |
| 0.84 | TLK | Telkom Indonesia Tbk | PairCorr |
| 0.83 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
| 0.83 | PFE | Pfizer Inc Aggressive Push | PairCorr |
| 0.75 | JNJ | Johnson Johnson Sell-off Trend | PairCorr |
| 0.71 | TCHH | Trustcash Holdings | PairCorr |
| 0.66 | EC | Ecopetrol SA ADR | PairCorr |
| 0.6 | SHG | Shinhan Financial | PairCorr |
| 0.5 | MMM | 3M Company Fiscal Year End 28th of January 2025 | PairCorr |
Acasti Pharma Market Sensitivity And Downside Risk
Acasti Pharma's beta coefficient measures the volatility of Acasti stock compared to the systematic risk of the entire market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents Acasti stock's returns against your selected market. In other words, Acasti Pharma's beta of 0.41 provides an investor with an approximation of how much risk Acasti Pharma stock can potentially add to one of your existing portfolios. Acasti Pharma shows above-average downside volatility for the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Acasti Pharma's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Acasti Pharma's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.
3 Months Beta |Analyze Acasti Pharma Demand TrendCheck current 90 days Acasti Pharma correlation with market (Dow Jones Industrial)Acasti Beta |
Acasti standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. A typical volatile entity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.
Standard Deviation | 4.96 |
It is essential to understand the difference between upside risk (as represented by Acasti Pharma's standard deviation) and the downside risk, which can be measured by semi-deviation or downside deviation of Acasti Pharma's daily returns or price. Since the actual investment returns on holding a position in acasti stock tend to have a non-normal distribution, there will be different probabilities for losses than for gains. The likelihood of losses is reflected in the downside risk of an investment in Acasti Pharma.
Acasti Pharma Stock Volatility Analysis
Volatility refers to the frequency at which Acasti Pharma delisted stock price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with Acasti Pharma's price changes. Investors will then calculate the volatility of Acasti Pharma's stock to predict their future moves. A delisted stock that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A stock with relatively stable price changes has low volatility. A highly volatile delisted stock is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of Acasti Pharma's volatility:
Historical Volatility
This type of delisted stock volatility measures Acasti Pharma's fluctuations based on previous trends. It's commonly used to predict Acasti Pharma's future behavior based on its past. However, it cannot conclusively determine the future direction of the stock.Implied Volatility
This type of volatility provides a positive outlook on future price fluctuations for Acasti Pharma's current market price. This means that the delisted stock will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on Acasti Pharma's to be redeemed at a future date.Transformation |
We are not able to run technical analysis function on this symbol. We either do not have that equity or its historical data is not available at this time. Please try again later.
Acasti Pharma Projected Return Density Against Market
Given the investment horizon of 90 days Acasti Pharma has a beta of 0.4076 . This suggests as returns on the market go up, Acasti Pharma average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Acasti Pharma will be expected to be much smaller as well.Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Acasti Pharma or Pharmaceuticals sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Acasti Pharma's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Acasti delisted stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Acasti Pharma has an alpha of 0.2957, implying that it can generate a 0.3 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Predicted Return Density |
| Returns |
What Drives an Acasti Pharma Price Volatility?
Several factors can influence a delisted stock's market volatility:Industry
Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.Political and Economic environment
When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.The Company's Performance
Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.Acasti Pharma Stock Risk Measures
Given the investment horizon of 90 days the coefficient of variation of Acasti Pharma is 551.67. The daily returns are distributed with a variance of 24.62 and standard deviation of 4.96. The mean deviation of Acasti Pharma is currently at 3.57. For similar time horizon, the selected benchmark (Dow Jones Industrial) has volatility of 0.77
α | Alpha over Dow Jones | 0.30 | |
β | Beta against Dow Jones | 0.41 | |
σ | Overall volatility | 4.96 | |
Ir | Information ratio | 0.05 |
Acasti Pharma Stock Return Volatility
Acasti Pharma historical daily return volatility represents how much of Acasti Pharma delisted stock's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The firm inherits 4.9617% risk (volatility on return distribution) over the 90 days horizon. By contrast, Dow Jones Industrial accepts 0.7626% volatility on return distribution over the 90 days horizon. Performance |
| Timeline |
About Acasti Pharma Volatility
Volatility is a rate at which the price of Acasti Pharma or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of Acasti Pharma may increase or decrease. In other words, similar to Acasti's beta indicator, it measures the risk of Acasti Pharma and helps estimate the fluctuations that may happen in a short period of time. So if prices of Acasti Pharma fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. The company was incorporated in 2002 and is headquartered in Laval, Canada. Acasti Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange.
Acasti Pharma's stock volatility refers to the amount of uncertainty or risk involved with the size of changes in its stock's price. It is a statistical measure of the dispersion of returns on Acasti Stock over a specified period of time, often expressed as the standard deviation of daily returns. In other words, it measures how much Acasti Pharma's price varies over time.
3 ways to utilize Acasti Pharma's volatility to invest better
Higher Acasti Pharma's stock volatility means that the price of its stock is changing rapidly and unpredictably, while lower stock volatility indicates that the price of Acasti Pharma stock is relatively stable. Investors and traders use stock volatility as an indicator of risk and potential reward, as stocks with higher volatility can offer the potential for more significant returns but also come with a greater risk of losses. Acasti Pharma stock volatility can provide helpful information for making investment decisions in the following ways:- Measuring Risk: Volatility can be used as a measure of risk, which can help you determine the potential fluctuations in the value of Acasti Pharma investment. A higher volatility means higher risk and potentially larger changes in value.
- Identifying Opportunities: High volatility in Acasti Pharma's stock can indicate that there is potential for significant price movements, either up or down, which could present investment opportunities.
- Diversification: Understanding how the volatility of Acasti Pharma's stock relates to your other investments can help you create a well-diversified portfolio of assets with varying levels of risk.
Acasti Pharma Investment Opportunity
Acasti Pharma has a volatility of 4.96 and is 6.53 times more volatile than Dow Jones Industrial. 44 percent of all equities and portfolios are less risky than Acasti Pharma. You can use Acasti Pharma to protect your portfolios against small market fluctuations. The stock experiences a normal downward trend and little activity. Check odds of Acasti Pharma to be traded at $3.34 in 90 days.Significant diversification
The correlation between Acasti Pharma and DJI is 0.07 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Acasti Pharma and DJI in the same portfolio, assuming nothing else is changed.
Acasti Pharma Additional Risk Indicators
The analysis of Acasti Pharma's secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in Acasti Pharma's investment and either accepting that risk or mitigating it. Along with some common measures of Acasti Pharma stock's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Risk Adjusted Performance | 0.0704 | |||
| Market Risk Adjusted Performance | 0.8562 | |||
| Mean Deviation | 3.0 | |||
| Semi Deviation | 2.83 | |||
| Downside Deviation | 3.1 | |||
| Coefficient Of Variation | 1233.46 | |||
| Standard Deviation | 4.38 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential stocks, we recommend comparing similar delisted stocks with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Acasti Pharma Suggested Diversification Pairs
Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Acasti Pharma as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Acasti Pharma's systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Acasti Pharma's unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Acasti Pharma.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Consideration for investing in Acasti Stock
If you are still planning to invest in Acasti Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Acasti Pharma's history and understand the potential risks before investing.
| Stocks Directory Find actively traded stocks across global markets | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |